Indrayani Biotech standalone net profit rises 1485.71% in the March 2025 quarter

Sales decline 41.27% to Rs 9.28 crore

Net profit of Indrayani Biotech rose 1485.71% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 0.07 crore during the previous quarter ended March 2024. Sales declined 41.27% to Rs 9.28 crore in the quarter ended March 2025 as against Rs 15.80 crore during the previous quarter ended March 2024.

For the full year,net profit declined 0.68% to Rs 1.45 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales declined 39.39% to Rs 37.77 crore in the year ended March 2025 as against Rs 62.32 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	9.28	15.80	-41	37.77	62.32	-39
OPM %	18.53	6.27	-	14.48	9.10	-
PBDT	0.26	1.97	-87	1.67	4.46	-63
PBT	0.20	1.62	-88	0.65	3.01	-78
NP	1.11	0.07	1486	1.45	1.46	-1

Powered by Capital Market - Live News